What is Semaglutide?
It acts as a GLP-1 receptor agonist. This increases intracellular cyclic AMP (cAMP) leading to insulin release in the presence of elevated glucose concentrations.
13
Dec
Blog
13
Dec
What effects does Semaglutide have on HbA1c?
Semaglutide reduces HbA1c across baseline HbA1c subgroups across Sustain 1-5 Clinical Trials.
27
Aug
Gastric bypass without surgery!
On June 4, 2021 The FDA approved Semaglutide for weight loss! This approval allows prescribed patients to receive up to 2.4 mg once weekly
